Netflix Inc. sell BiotechBee
Start price
17.07.23
/
60%
€395.00
Target price
30.06.25
€360.00
Performance (%)
-2.59%
End price
25.07.23
€384.75
Summary
This prediction ended on 25.07.23 with a price of €384.75. With a performance of -2.59%, the SELL prediction by BiotechBee was trending in the right direction. BiotechBee has 60% into this predictionNetflix Inc. is a leading entertainment company that offers online streaming of movies and TV shows through its subscription-based streaming platform. The company provides a vast selection of content that can be accessed on several devices, including smart TVs, gaming consoles, smartphones, and tablets. Netflix has consistently grown its subscriber base and revenue over the years, owing to its innovative approach to content creation and distribution, which has made it a darling of investors and a sought-after stock on Wall Street.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Netflix Inc. | -1.245% | -1.245% | 54.861% |
| iShares Core DAX® | -0.543% | 1.491% | 13.638% |
| iShares Nasdaq 100 | -2.696% | -1.235% | 31.879% |
| iShares Nikkei 225® | -2.863% | 2.491% | 12.078% |
| iShares S&P 500 | -1.105% | 0.013% | 26.888% |
According to BiotechBee what are the pros and cons of Netflix Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Netflix Inc. diskutieren
Sell mit Kursziel 360,0